IPO Insider



Highlighted IPO


On July 1, 2015, the IPO Teladoc, Inc. (NYSE: TDOC) opened for trading at $29.90 after pricing 8,250,000 shares of its common stock at a price to the public of $19.00 per share, above the recently expected range of $15 to $17 per share.

J.P. Morgan Securities LLC and Deutsche Bank Securities Inc. are acting as joint book-running managers for the offering. William Blair & Company, L.L.C., Wells Fargo Securities, LLC and SunTrust Robinson Humphrey, Inc. are acting as co-managers for the offering.

Teladoc is the nation's first and largest telehealth platform, delivering on-demand healthcare anytime, anywhere, via mobile devices, the internet, video and phone.


Recently Priced IPOs

Date Company Ticker Shares IPO Price Current % Underwriters
1/20/2017 Keane Group FRAC 26.76 Mil $19.00 $22.13 16.47% Citigroup, Morgan Stanley, BofA Merrill Lynch, and J.P. Morgan
12/16/2016 trivago TRVG 26.1 Bil $11.00 $11.75 6.82% .P. Morgan Securities LLC, Goldman, Sachs & Co. and Morgan Stanley & Co. LLC
12/14/2016 WildHorse Resource Development WRD 27.5 Mil $15.00 $14.60 -2.67% Barclays, BofA Merrill Lynch, BMO Capital Markets, Citigroup and Wells Fargo
12/8/2016 SenesTech SNES 1.875 Mil $8.00 $8.15 1.88% Roth Capital Partners
12/7/2016 Polar Power POLA 2.4 Mil $7.00 $8.95 27.86% Roth Capital Partners and Joseph Gunnar & Co
11/18/2016 Motif Bio plc MTFB 2.44 Mil $6.98 $6.19 -11.32% H.C. Wainwright
11/4/2016 Smart Sand SND 11.7 Mil $11.00 $16.55 50.45%
11/2/2016 GDS Holdings GDS 19.25 Mil $10.00 $8.60 -14.00% Credit Suisse, JPMorgan, Citigroup, RBC, China Renaissance
10/28/2016 Acushnet Holdings GOLF 19.333 Mil $17.00 $19.71 15.94% J.P. Morgan, Morgan Stanley
10/28/2016 BlackLine BL 8.6 Mil $17.00 $27.63 62.53% Goldman, Sachs & Co. and J.P. Morgan

Upcoming IPOs

Date Company Ticker Shares Expected Price Underwriters
N/AViamet Pharmaceuticals Corp.VMETN/AN/AMorgan Stanley, Goldman, Sachs & Co., Guggenheim Securities, Needham & Company
N/AMassRoots, Inc.MSRTN/AN/AChardan Capital Markets
N/AGemphire TherapeuticsGEMPN/AN/AJefferies and Cowen
N/AOrthoPediatrics Corp.KIDSN/AN/APiper Jaffray & Co., Stifel, Nicolaus & Company, William Blair & Company, BTIG
N/AYETI Holdings, Inc.YETIN/AN/ABofA Merrill Lynch, Morgan Stanley, Baird, Piper Jaffray, Jefferies, William Blair, KeyBanc Capital Markets, SunTrust Robinson Humphrey, Wells Fargo Securities, Raymond James, Stifel, Academy Securities
N/AMyovant Sciences Ltd.MYOVN/AN/ACitigroup, Cowen and Company, Evercore ISI, Barclays
N/AClipper Realty Inc.CLPRN/AN/AFBR
N/ABeyondSpring BYSIN/AN/ACitigroup, Guggenheim Securities, FBR, China Renaissance, Trout Capital
N/AArdagh Finance Holdings S.A.ARDN/AN/ACitigroup
N/AJBS Foods International B.V.JBSN/AN/A

Upcoming IPO

Blue Buffalo Pet Products (NASDAQ: BUFF) filed $500M IPO with the SEC. The company plans to list under symbol "BUFF" on the NASDAQ.

The offering is being led by JPMorgan and Citigroup, with Barlcys, Deutsche Bank, Morgan Stanley, Wells Fargo and LOYAL3 Securities also listed in support.

Blue Buffalo Pet Products is the fastest growing major pet food company in the United States, selling dog and cat food made with whole meats, fruits and vegetables, and other high-quality, natural ingredients. BLUE is a billion dollar brand based on sales at retail and is the #1 brand in the Wholesome Natural market segment. They currently have approximately 6% share of the overall pet food industry and feed only 2-3% of the 164 million pets in the United States.